These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30355364)

  • 1. High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.
    Graham B; Garcia NM; Burton MS; Cooper AA; Roy-Byrne PP; Mavissakalian MR; Feeny NC; Zoellner LA
    Br J Psychiatry; 2018 Dec; 213(6):704-708. PubMed ID: 30355364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale.
    Davidson JR
    Int Clin Psychopharmacol; 2004 Mar; 19(2):85-7. PubMed ID: 15076016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.
    Sonne C; Carlsson J; Bech P; Elklit A; Mortensen EL
    BMC Psychiatry; 2016 Nov; 16(1):383. PubMed ID: 27825327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression sudden gains and transient depression spikes during treatment for PTSD.
    Keller SM; Feeny NC; Zoellner LA
    J Consult Clin Psychol; 2014 Feb; 82(1):102-11. PubMed ID: 24364793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
    Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
    Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.
    Friedman MJ; Marmar CR; Baker DG; Sikes CR; Farfel GM
    J Clin Psychiatry; 2007 May; 68(5):711-20. PubMed ID: 17503980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sertraline in posttraumatic stress disorder secondary to interpersonal trauma or childhood abuse.
    Stein DJ; van der Kolk BA; Austin C; Fayyad R; Clary C
    Ann Clin Psychiatry; 2006; 18(4):243-9. PubMed ID: 17162624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden gains in prolonged exposure and sertraline for chronic PTSD.
    Jun JJ; Zoellner LA; Feeny NC
    Depress Anxiety; 2013 Jul; 30(7):607-13. PubMed ID: 23633445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of sertraline in post-traumatic stress disorder.
    Schwartz AC; Rothbaum BO
    Expert Opin Pharmacother; 2002 Oct; 3(10):1489-99. PubMed ID: 12387695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial.
    Buhmann CB; Nordentoft M; Ekstroem M; Carlsson J; Mortensen EL
    Br J Psychiatry; 2016 Mar; 208(3):252-9. PubMed ID: 26541687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in temporal attention inhibition following prolonged exposure and sertraline in the treatment of PTSD.
    Echiverri-Cohen A; Zoellner LA; Gallop R; Feeny N; Jaeger J; Bedard-Gilligan M
    J Consult Clin Psychol; 2016 May; 84(5):415-26. PubMed ID: 26900894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment.
    Bossini L; Tavanti M; Lombardelli A; Calossi S; Polizzotto NR; Galli R; Vatti G; Pieraccini F; Castrogiovanni P
    J Clin Psychopharmacol; 2007 Apr; 27(2):233-5. PubMed ID: 17414261
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
    Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline approved for post-traumatic stress disorder.
    Gottlieb S
    BMJ; 1999 Oct; 319(7217):1089. PubMed ID: 10610144
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
    Davidson J; Pearlstein T; Londborg P; Brady KT; Rothbaum B; Bell J; Maddock R; Hegel MT; Farfel G
    Am J Psychiatry; 2001 Dec; 158(12):1974-81. PubMed ID: 11729012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline in the treatment of rape victims with posttraumatic stress disorder.
    Rothbaum BO; Ninan PT; Thomas L
    J Trauma Stress; 1996 Oct; 9(4):865-71. PubMed ID: 8902752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the effects of sertraline in post-traumatic stress disorder.
    Davidson JR; Landerman LR; Farfel GM; Clary CM
    Psychol Med; 2002 May; 32(4):661-70. PubMed ID: 12102380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.